Ford - Ford's shares are rising despite announcing a $19.5 billion special charge primarily related to a pullback in EV investments and a broader business restructuring [2][4] - The company reassured investors that these charges will not impact adjusted earnings, raising their 2025 adjusted EBIT outlook to approximately $7 billion [3][4] - Ford is refocusing on hybrids, smaller EVs, and core trucks and SUVs while reducing investments in unprofitable electric models, which has led to a positive market reaction [4][5] Pfizer - Pfizer's stock reaction to its guidance has been lackluster, forecasting a 2026 profit outlook below Wall Street expectations [6][7] - The company projects adjusted EPS for fiscal year 2026 to be between $2.80 and $3, while the market expected $3.06 [7] - Pfizer anticipates a revenue hit of $1.5 billion in 2026 due to key older drugs losing exclusivity, contributing to challenges in maintaining a robust drug pipeline [9] Lockheed Martin - Lockheed Martin has been downgraded by Morgan Stanley from overweight to equal weight, with a price target cut from $630 to $543 [10][11] - The downgrade is attributed to underperformance compared to peers and concerns over disruption risks from emerging technologies [12] - Execution issues and pension headwinds are also expected to exert pressure on the company's performance in major segments [13]
Ford (F) Taking $19.5B EV Charge, PFE Guidance Down, LMT Downgrade